Does TYK2/JAK1 Show Potential in Inflammatory Diseases? - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.

  • By

  • Andrea Surnit

  • July 6, 2026

  • 3 min

Share

Original Source(s)

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

  • by Andrea Surnit

  • July 6, 2026

Related Content

FDA approves oral dermatomyositis therapy

Phase 3 findings show improvements in physical function and skin disease activity.

Spondyloarthritis function varies by sex

Women had greater functional deterioration over 17 years, while permanent work disability did not differ significantly between sexes.

Tenderness Tracks Ultrasound Findings

Joint tenderness showed broader associations with concurrent ultrasound abnormalities than patient-reported pain among anti-cyclic citrullinated peptide–positive patients without clinical arthritis.